SCHEMBL22018289

SCHEMBL22018289

Cc1cc(I)nc(N2C[C@H]3CNC[C@H]3C2)n1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 16/20 0.43
HCRTR2 O43614 16/20 0.43
BPTF Q12830 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29117985 0.89 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL21963537 0.89 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL1670922 0.89 HCRTR1 (0.51) HCRTR1HCRTR2
Hydrochloric Acid SCHEMBL29367258 0.87 HCRTR1 (0.50) HCRTR1HCRTR2
Hydrochloric Acid SCHEMBL15796256 0.87 HCRTR1 (0.50) HCRTR1HCRTR2
SCHEMBL6923122 0.81 HCRTR1 (0.44) HCRTR1HCRTR2
SCHEMBL29118005 0.78 ROCK2 (0.50) HCRTR1HCRTR2
SCHEMBL29118006 0.78 ROCK2 (0.50) HCRTR1HCRTR2
SCHEMBL29118052 0.78 ROCK2 (0.50) HCRTR1HCRTR2
SCHEMBL29614755 0.78 HCRTR1 (0.43) HCRTR1HCRTR2BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020100011-A1 IMPROVED SYNTHETIC METHODS OF MAKING FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-05-22 WO disclosed